Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Gordon A. Langston who wrote (1653)	9/26/1998 9:35:00 PM
From: majormember	Read Replies (1) \| Respond to of 4140

>>will a spike occur and will it be sustained till FDA. Gordon, If you look at the PMA dates of VISX and BEAM, they both had a spike up, then a significant surge upon FDA approval. SNRS does not seem to be performing as well as either of the two mentioned above, so it's hard to tell if the performance will be replicated. Of course the Street seems to be in more of a "show me the profits" mood before putting high valuations on stocks. The notable exceptions would be AMZN and the internets, where earning's seem to have no relevancy to share price. Regards, Skane